Although we measured changes in ADAM17 protein expression in purified microvascular preparations, the expressional changes in other aforementioned cell types could have an impact on AD related neuropathological changes and memory and cognitive function in the APP/PS1 mice, which has yet to be delineated in future studies. The gene discussed is APP; the disease is Alzheimer disease.